The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases

By Brankin Eamonn   Walker Mel   Lynch Niall   Aspray Terence   Lis Yvonne   Cowell Warren  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1249-1256

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis

By Penning-van Beest Fernie J. A.   Erkens Joëlle A.   Olson M.   Herings Ron M. C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1337-1344

Informa Healthcare

Access to resources Recommend Favorite

Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

By Barrett-Connor E.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 733-741

Springer Publishing Company

Access to resources Recommend Favorite

Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy

By Gold Deborah T.   Trinh Haian   Safi Wael  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1831-1839

Informa Healthcare

Access to resources Recommend Favorite